Yoon Young Kyung, Kwon Ki Tae, Jeong Su Jin, Moon Chisook, Kim Bongyoung, Kiem Sungmin, Kim Hyung-Sook, Heo Eunjeong, Kim Shin-Woo
Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Korean Society for Antimicrobial Therapy, Seoul, Korea.
Infect Chemother. 2021 Sep;53(3):617-659. doi: 10.3947/ic.2021.0098.
These guidelines were developed as a part of the 2021 Academic R&D Service Project of the Korea Disease Control and Prevention Agency in response to requests from healthcare professionals in clinical practice for guidance on developing antimicrobial stewardship programs (ASPs). These guidelines were developed by means of a systematic literature review and a summary of recent literature, in which evidence-based intervention methods were used to address key questions about the appropriate use of antimicrobial agents and ASP expansion. These guidelines also provide evidence of the effectiveness of ASPs and describe intervention methods applicable in Korea.
这些指南是作为韩国疾病控制与预防机构2021年学术研发服务项目的一部分制定的，以回应临床实践中的医疗专业人员对制定抗菌药物管理计划（ASP）的指导要求。这些指南是通过系统的文献综述和近期文献总结制定的，其中使用基于证据的干预方法来解决关于抗菌药物合理使用和ASP扩展的关键问题。这些指南还提供了ASP有效性的证据，并描述了适用于韩国的干预方法。
